title: In vitro activity of tigecycline in combination with rifampin, doripenem or ceftazidime against carbapenem-resistant Klebsiella pneumoniae bloodstream isolates.
authors.affiliation: Department of Respiratory Medicine, An Qiu People's Hospital, Anqiu, China.
authors.forename: Yongbo
authors.initials: Y
authors.lastname: Zhang
authors.affiliation: Department of Respiratory Medicine, An Qiu People's Hospital, Anqiu, China.
authors.forename: Peizhen
authors.initials: P
authors.lastname: Li
authors.affiliation: Department of Respiratory Medicine, An Qiu People's Hospital, Anqiu, China.
authors.forename: Yuhan
authors.initials: Y
authors.lastname: Yin
authors.affiliation: Department of Clinical Laboratory, Liao Cheng Dong Chang Fu People's Hospital, Liaocheng, China.
authors.forename: Fuqiang
authors.initials: F
authors.lastname: Li
authors.affiliation: Department of Clinical Laboratory, Yi Shui People's Hospital, Yishui, China.
authors.forename: Qinghua
authors.initials: Q
authors.lastname: Zhang
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000494:pharmacology*; D015780:Carbapenems / Q000008:administration & dosage / Q000494:pharmacology; D002442:Ceftazidime / Q000008:administration & dosage / Q000494:pharmacology; D000077726:Doripenem; D024881:Drug Resistance, Bacterial; D004357:Drug Synergism; D006801:Humans; D007710:Klebsiella Infections / Q000382:microbiology*; D007711:Klebsiella pneumoniae / Q000187:drug effects*; D008826:Microbial Sensitivity Tests; D008911:Minocycline / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000494:pharmacology; D012293:Rifampin / Q000008:administration & dosage / Q000494:pharmacology; D000078304:Tigecycline
chemical_list: D000900:Anti-Bacterial Agents; D015780:Carbapenems; D000078304:Tigecycline; D002442:Ceftazidime; D000077726:Doripenem; D008911:Minocycline; D012293:Rifampin